awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36864032-57F805FA-84C6-47E0-BB11-B15C14537840
Q36864032-57F805FA-84C6-47E0-BB11-B15C14537840
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36864032-57F805FA-84C6-47E0-BB11-B15C14537840
Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer.
P2860
Q36864032-57F805FA-84C6-47E0-BB11-B15C14537840
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36864032-57F805FA-84C6-47E0-BB11-B15C14537840
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
21dadc3945633b22035d109de23e14aca504ccab
P2860
Cediranib/AZD2171 inhibits bone and brain metastasis in a preclinical model of advanced prostate cancer.